Preeclamptic Placental Mesenchymal Stem Cell Conditioned Medium for Use in the Treatment of a Tumour
AssigneeCORION BIOTECH S/r.L.
InventorsAlessandro Rolfo, Tullia Todros
Life of this patent
Estimating the term…
Abstract
It is described a conditioned medium (CM) obtainable by culturing, in a liquid culture medium, placental mesenchymal stem cells from a preeclamptic placenta. The conditioned medium object of the invention includes at least IP-10 and TARC proteins and it is used for the therapeutic treatment of a tumor, preferably an epithelial tumor.
Claims17
A conditioned medium obtainable by culturing a placental mesenchymal stem cell from a preeclamptic placenta in a serum-free basal liquid culture medium, the conditioned medium comprising at least interferon gamma-induced protein 10 (IP-10) and thymus activation-regulated chemokine (TARC), for use in the therapeutic treatment of a tumor.
A pharmaceutical composition for use in the therapeutic treatment of a tumor, comprising at least interferon gamma-induced protein 10 (IP-10) and thymus activation-regulated chemokine (TARC), and optional pharmaceutically acceptable vehicles, excipients and/or diluents.
Dependencies are inferred from the claim text.